| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/02/2004 | EP1374891A1 Method for accelerating the rate of mucociliary clearance |
| 01/02/2004 | EP1374890A2 Thrombopoietin compositions for increasing circulating platelets |
| 01/02/2004 | EP1374883A1 Nasal spray containing a plant extract for the treatment of diseases such as herpes zoster, hematoma, mastitis and cardiovasculatory weakness |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1374874A2 Liquid antacid compositions |
| 01/02/2004 | EP1374872A1 Pharmaceutical preparations comprising a combination of at least one representative of antibiotics and one of antiphlogistics, process for manufacturing, and use thereof |
| 01/02/2004 | EP1374864A1 Amphiphilic taxane compositions |
| 01/02/2004 | EP1374861A1 External preparations for treating dermatoses |
| 01/02/2004 | EP1374860A1 Polymer coated microparticles for sustained release |
| 01/02/2004 | EP1374859A1 Solid pharmaceutical composition comprising tilidine hydrochloride |
| 01/02/2004 | EP1374858A2 Quick-disintegrating tablet in the buccal cavity and manufacturing method thereof |
| 01/02/2004 | EP1374856A1 Oily thixotropic nasal spray |
| 01/02/2004 | EP1374855A1 Medicinal solutions |
| 01/02/2004 | EP1374854A1 Delayed release pharmaceutical composition, method of production and use of said composition |
| 01/02/2004 | EP1374847A1 Stable hydroalcoholic compositions |
| 01/02/2004 | EP1374703A1 Use of a non-human animal embryo extract for the preparation of a nutritive substance and a dietetic-nutraceutical supplement |
| 01/02/2004 | EP1373472A1 Methods and gel compositions for encapsulating living cells and organic molecules |
| 01/02/2004 | EP1373277A1 Organometallic building materials and method for producing the same |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372777A1 Embolic devices capable of in-situ reinforcement |
| 01/02/2004 | EP1372758A1 Method for eliminating potentially toxic and/or harmful substances |
| 01/02/2004 | EP1372739A2 Stabilized therapeutic and imaging agents |
| 01/02/2004 | EP1372737A2 Preparation for the prophylaxis of restenosis |
| 01/02/2004 | EP1372730A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 01/02/2004 | EP1372729A1 Erodible polymers for injection |
| 01/02/2004 | EP1372728A1 Compositions comprising an o/w emulsion containing conjugated linoleic acid |
| 01/02/2004 | EP1372726A1 Methods for reducing fat by administration of adiponectin |
| 01/02/2004 | EP1372717A2 Combination treatment of pancreatic cancer |
| 01/02/2004 | EP1372708A2 Vaccine for transcutaneous immunization |
| 01/02/2004 | EP1372700A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 01/02/2004 | EP1372694A1 Liposome targeting of matrix metalloproteinase inhibitors |
| 01/02/2004 | EP1372693A2 Peptides for the treatment of wound contracture |
| 01/02/2004 | EP1372673A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 01/02/2004 | EP1372672A1 Prophylactic teat treatment |
| 01/02/2004 | EP1372671A2 Methylated promoters for intraductal treatment of breast cancer |
| 01/02/2004 | EP1372669A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 01/02/2004 | EP1372667A2 Compositions for delivering bisphosphonates |
| 01/02/2004 | EP1372666A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial / matrix adhesion such as asthma, cystic fibrosis and influenza |
| 01/02/2004 | EP1372662A1 Taste masked liquid pharmaceutical compositions |
| 01/02/2004 | EP1372649A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 01/02/2004 | EP1372645A1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/02/2004 | EP1372637A2 Premixed amiodarone parenteral solution and method for making the same |
| 01/02/2004 | EP1372631A1 Method and formula for anti-tumor and anti-matastatic effect |
| 01/02/2004 | EP1372628A2 Paracetamol solutions which are stable in storage and ready for infusion |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372619A2 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 01/02/2004 | EP1372618A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 01/02/2004 | EP1372617A2 Enteric ketoacid salts and amino acids and their use for preparing medicines |
| 01/02/2004 | EP1372616A2 A stable pharmaceutical composition of pravastatin |
| 01/02/2004 | EP1372615A1 Compounds and compositions for delivering active agents |
| 01/02/2004 | EP1372614A1 Controlled release sulfonylurea formulation |
| 01/02/2004 | EP1372612A1 A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same |
| 01/02/2004 | EP1372611A2 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
| 01/02/2004 | EP1372610A2 Powder inhaler formulations |
| 01/02/2004 | EP1372609A2 Peat product composition, method for the production and use thereof |
| 01/02/2004 | EP1372608A1 Medical aerosol formulations |
| 01/02/2004 | EP1372607A1 Adjuvant emulsion and method of using said emulsion |
| 01/02/2004 | EP1372606A2 In-situ gel formation of pectins |
| 01/02/2004 | EP1372605A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 01/02/2004 | EP1372604A2 Manufacturing dissolvable dosage forms |
| 01/02/2004 | EP1372603A1 Topical application for treating toenail fungus |
| 01/02/2004 | EP1372602A2 Flexible microchip devices for ophthalmic and other applications |
| 01/02/2004 | EP1372599A2 Skin care products with improved skin and material softness |
| 01/02/2004 | EP1372597A1 Metronidazole pledgets |
| 01/02/2004 | EP1372573A2 Thermally reversible water in oil in water emulsions |
| 01/02/2004 | EP1372553A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 01/02/2004 | EP1372548A1 Prosthetic foot with tunable performance |
| 01/02/2004 | EP1372547A1 Prosthetic foot with tunable performance |
| 01/02/2004 | EP1372546A2 Prosthetic foot with tunable performance |
| 01/02/2004 | EP1372545A2 Prosthetic foot with tunable performance |
| 01/02/2004 | EP1372528A2 Mucosal boosting following parenteral priming |
| 01/02/2004 | EP1372492A1 Immobilizing objects in the body |
| 01/02/2004 | EP1372394A1 Antifungal composition with enhanced bioavailability |
| 01/02/2004 | EP1372392A1 Nicotine-containing oral dosage form |
| 01/02/2004 | EP1372385A1 Aqeuous suspension of nanoparticles comprising an agrochemical active ingredient |
| 01/02/2004 | EP1372383A2 Antimicrobial formulations |
| 01/02/2004 | EP0970131B1 Particulate drug carriers |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/01/2004 | US20040002692 Applying in situ; biodegradation; cardiovascular disorders; anticancer agents |
| 01/01/2004 | US20040002675 Mutlilayer; backing, aluminum layer and pressure sensitive adhesive |
| 01/01/2004 | US20040002647 Gel injection treatment of body parts |
| 01/01/2004 | US20040002560 Elastomer gels; soft three-dimensional toys |
| 01/01/2004 | US20040002548 Therapy for respiratory system disorders |
| 01/01/2004 | US20040002544 Antidiabetic preparation for oral administration |
| 01/01/2004 | US20040002522 Antiinflammatory agents; analgesics |
| 01/01/2004 | US20040002520 Applying mixture to oral cavity a solution of nicotine and water |
| 01/01/2004 | US20040002517 Alzheimer's disease |
| 01/01/2004 | US20040002510 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| 01/01/2004 | US20040002502 Respiratory system disorders; antiinflammatory agents |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002472 Vaccination or immunization using a prime-boost regimen |
| 01/01/2004 | US20040002461 Amelioration of the development of cataracts and other ophthalmic diseases |
| 01/01/2004 | US20040002454 Administering polypeptides; cardiovascular disorders |
| 01/01/2004 | US20040002451 Antiinflammatory agents; stability, reduced viscosity; immobilization |
| 01/01/2004 | US20040001892 Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology |
| 01/01/2004 | US20040001891 Encapsulated dry powder; mixture of polymer, silica, corn starch and perfume; spray drying |
| 01/01/2004 | US20040001890 Administering by injection; core of biodegradable polymer, drugs and overcoating; sustained released |
| 01/01/2004 | US20040001889 Short duration depot formulations |
| 01/01/2004 | US20040001888 Solid dosage forms for rapid dissolution of poorly soluble drugs |